Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02940353 · ClinicalTrials.gov registry record · NA
The TREFOIL Concept 5 Year Clinical Investigation
A NA study of Edentulous or Failing Dentition Mandible, sponsored by Nobel Biocare.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 5
- Study locations
NCT02940353: Completed NA study of Edentulous or Failing Dentition Mandible, sponsored by Nobel Biocare.
NCT02940353 is a NA study of Edentulous or Failing Dentition Mandible that has completed, run by Nobel Biocare. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02940353, a NA study of Edentulous or Failing Dentition Mandible, has completed, sponsored by Nobel Biocare.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 5
- Study locations
Study Summary
Prospective, single cohort, multi-center study evaluating the TREFOIL concept for the treatment of edentulous or patients with failing mandibular dentition over 5 years. 90 patients (15 per centre) will be included. The subject population is at least 18 years old, in need of an implant restored full prosthesis providing sufficient bone in the interforaminal where a fixed restoration on three implants is regarded as an appropriate treatment solution. The components are TREFOIL treatment concept (implants and framework).
Conditions Studied
Interventions
- DEVICE TREFOIL concept
Study Locations (5)
Other
- University of Verona - Verona
- Instituto Davó, Hospital Medimar Internacional - Alicante
Washington
- Dr. Higuchi &Skinner - Spokane
Western Australia
- Branemark Centre - Perth
Santiago de Chile
- Clinica Rosenberg - Santiago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2016-04 |
| Est. Completion | 2022-06 |
| Phase | NA |
What the finished NCT02940353 record still lists
NCT02940353 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Edentulous or Failing Dentition Mandible appearing as the primary indexed condition, and to 1 intervention - of which TREFOIL concept is the first listed.
NCT02940353 lists 5 locations in 4 states (Other, Washington, Western Australia).
Frequently Asked Questions
What is clinical trial NCT02940353 about?
NCT02940353 is a clinical study titled "The TREFOIL Concept 5 Year Clinical Investigation". Prospective, single cohort, multi-center study evaluating the TREFOIL concept for the treatment of edentulous or patients with failing mandibular dentition over 5 years. 90 patients (15 per centre) will be included. The subject population is at least 18 years old, in need of an implant restored full...
What is the current status of trial NCT02940353?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2016-04. Estimated completion is 2022-06.
What conditions does trial NCT02940353 study?
This clinical trial studies the following conditions: Edentulous or Failing Dentition Mandible.
What interventions are being tested in trial NCT02940353?
The interventions under investigation include: TREFOIL concept (DEVICE).
Who is sponsoring clinical trial NCT02940353?
This trial is sponsored by Nobel Biocare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02940353 being conducted?
This trial has 5 study locations across Washington, Western Australia, Santiago de Chile. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02940353's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia